# Study to Evaluate DNL151 in Subjects With Parkinson's Disease

> **NCT04056689** · PHASE1 · COMPLETED · sponsor: **Biogen** · enrollment: 36 (actual)

## Conditions studied

- Parkinson's Disease

## Interventions

- **DRUG:** DNL151
- **DRUG:** Placebo

## Key facts

- **NCT ID:** NCT04056689
- **Lead sponsor:** Biogen
- **Sponsor class:** INDUSTRY
- **Phase:** PHASE1
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2019-07-23
- **Primary completion:** 2020-12-02
- **Final completion:** 2020-12-02
- **Target enrollment:** 36 (ACTUAL)
- **Last updated:** 2023-04-18


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT04056689

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT04056689, "Study to Evaluate DNL151 in Subjects With Parkinson's Disease". Retrieved via AI Analytics 2026-06-12 from https://api.ai-analytics.org/clinical/NCT04056689. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*